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1. Introduction
  Trypanosomosis, an infection caused by organisms of the 
genus Trypanosoma is the most economically important 
disease in sub-Saharan Africa[1]. The loss in livestock 
production and mixed agriculture alone is valued at 5 
billion US dollars yearly in Africa[2]. It is currently estimated 
that about 60 million people and 48 million cattle[3] are 
at risk of contracting African trypanosomiasis from the 
23 species and 33 sub species of tsetse flies infesting 10 
million km2 of Africa stretching across 40 countries. Tsetse 
transmitted African trypanosomosis is responsible for 55 000 
human and 3 million livestock deaths annually[3] and this 
hinders mixed farming through reduced work efficiency of 
draft animals. One most commonly used drug to control and 
treat the disease is diminazene. Several limitations to the 
use of diminazene as a trypanocides are high cost[1], drug 
resistance[4], and relapse of infection[5]. Azadirachta indica 
(A. indica) (Neem) is a medicinal plant used in traditional 
medicine for the treatment of pests[6], fungal[7], bacterial[8], 
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viral[7] and trypanosomal[9,10] infections. In Nigeria, it is 
popularly called “Dogonyaro”. Review of literature revealed 
that this medicinal plant remains unexplored in the area 
of combination therapy. With the increasing incidence of 
drug resistance and non-development or unavailability 
of new trypanocides, most current research efforts are 
directed towards making optimal use of the older drugs by 
combining them with enhancing agents[1,4]. This study was 
therefore designed to investigate the effects of combination 
of methanolic leaf extract of A. indica and diminazene 
diaceturate in the treatment of experimental Trypanosoma 
brucei (T. brucei) infection in rats.
2. Materials and methods
2.1. Experimental infection
  Each rat was experimentally infected with 1.25 伊 105 
trypanosomes in phosphate buffered saline (PBS) intra-
peritoneally (i.p). The number of parasites was assessed 
using standard method[11].
2.2. Trypanosomes
  Trypanosoma brucei brucei (T. brucei brucei) (field strain) 
was used for the study. The trypanosomes were obtained 
from donor rats infected with T. brucei brucei isolated from a 
dog clinically infected with T. brucei brucei.
2.3. Diminazene diaceturate
  A sachet of 2.36 g Diminaveto®, a product of VMD Holland 
marketed by TOSAM Nig. Ltd, containing 1.05 g diminazene 
diaceturate and 1.31 g antipyrine, NAFDAC Reg. No. 04-
2816, Man Date = 05-2008, Exp Date = 06-2013, Batch = 
DG/20278 was properly  reconstituted with normal saline and 
used for the study.
2.4. Experimental animals
  Adult albino rats weighing between 100 g and 120 g 
obtained from the Laboratory animal unit of Department 
of Veterinary Physiology and Pharmacology, University 
of Nigeria, Nsukka was used for the study. The rats 
were housed in clean cages in fly-proof house at room 
temperature (28-33 曟) and fed commercial feed (Vital 
feeds, GCOM Nig. Ltd) and provided with clean water ad 
libitum. The rats were screened for the presence of blood 
parasites using wet and Giemsa-stained thin films prior to 
commencement of the experiment.
2.5. Plant material and its extraction
  Fresh leaves of A. indica were collected from the Nsukka 
campus of University of Nigeria, Nsukka in June, 2008 
and were identified by plant taxonomist in the Botany 
Department of the University. Detailed description of the 
plant is available in literature[11]. The fresh leaves of A. 
indica were dried under mild sunlight. The dried leaves were 
pulverized using mortar and pestle into coarse particles. The 
material was finely ground with a grinding machine. Cold 
extraction was performed. 550 g of the powdered plant leaf 
was extracted in 1 500 mL of 80% methanol with intermittent 
shaking at intervals of 2 h for 48 h. The extract was filtered 
using What-man size-1 filter paper and concentrated in 
vacuo using vacuum rotatory evaporator connected to cold 
water circulator and pressure pump at 40 曟 and 210 mmHg 
pressures. The percentage yield was determined using the 
formulae: Yield = weight of material obtained divided by 
weight of starting material multiply by 100 over one. The 
extract, MAILE was then kept in the refrigerator at 4 曟 for 
use in the experiment.
2.6. Experimental design
2.6.1. Experiment 1: acute toxicity
  Thirty rats of both sexes divided into five groups of six 
each were used for the study. The MAILE was given orally 
and DDA, intra-peritoneally. The combination of DDA and 
the MAILE administered to different groups of rats is shown 
below.
  Group A: 7.0 mg/kg DDA plus 125 mg/kg MAILE. Group B: 
3.5 mg/kg DDA plus 250 mg/kg MAILE. Group C: 1.8 mg/kg 
DDA plus 500 mg/kg MAILE. Group D: 0.9 mg/kg DDA plus 1 
000 mg/kg MAILE. Group E: 7.0 mg/kg DDA plus 3 000 mg/kg 
MAILE
2.6.2. Experiments 2: selection of the best drug and extract 
combinations for use in the study
  Fifty four rats of both sexes were separated into 9 groups of 
six rats each were used. All the rats were infected with 1.25 
伊 105 trypanosomes given intra-peritoneally. DDA was given 
intra-peritoneally as a single dose, while the MAILE was 
given orally with the help of intra-gastric tube as a single 
dose. The treatments were administered when parasitaemia 
was established in all the rats (six days post infection). The 
DDA and MAILE combination administered is shown below.
  Group 1: 7.0 mg/kg DDA plus 125 mg/kg MAILE. Group 2: 
7.0 mg/kg DDA plus 250 mg/kg MAILE. Group 3: 7.0 mg/kg 
DDA plus 500 mg/kg MAILE. Group 4: 3.5 mg/kg DDA plus 
125 mg/kg MAILE. Group 5: 3.5 mg/kg DDA plus 250 mg/kg
MAILE. Group 6: 3.5 mg/kg DDA plus 500 mg/kg MAILE. 
Group 7: 1.8 mg/kg DDA plus 125 mg/kg MAILE. Group 8: 1.8 mg/kg
DDA plus 250 mg/kg MAILE. Group 9: 1.8 mg/kg DDA plus 
250 mg/kg MAILE
  Criteria for selection of best combination: Best combination 
that cleared the parasites with least dose was given 
preferential consideration. Any combination that did not 
clear the parasites after 7 days was discarded and the lowest 
mean was given preferential consideration. The experiment 
was terminated 7 days post treatment.
2.6.3. Experiment 3: efficacy study using combinations of 
DDA and MAILE
  Eighty four rats of both sexes divided into seven groups 
of twelve rats each were used for the study. Six groups 
were infected with T. brucei brucei organisms. Each rat 
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was infected with 1.25 伊 105 trypanosomes given intra-
peritoneally. Following the development of parasitaemia (6 
days post infection); each group was treated as indicated 
below.
  Group A: Infected and treated with 7.0 mg/kg DDA bw 
only. Group B: Infected and treated with 7.0 mg/kg DDA bw 
and 125 mg/kg bw MAILE. Group C: Infected and treated 
with 3.5 mg/kg DDA bw and 250 mg/kg bw MAILE. Group D: 
Infected and treated with 1.8 mg/kg DDA bw and 500 mg/kg 
bw MAILE. Group E: Infected and treated with 3 000 mg/kg 
bw MAILE only. Group F: Uninfected untreated. Group G: 
Uninfected untreated.
  Efficacy of the combination was determined using onset 
and level of parasitaemia (OP and LOP), clearance of 
parasites post treatment (COPPT), relapse infection period 
(RIP), and death. Moribund rats were euthanized using mild 
ether anaesthesia and considered as dead animals.
2.7. Parasitaemia
  Blood for detection of onset of parasitaemia (OP), level of 
parasitaemia (LOP), clearance of parasites post treatment 
(COPPT) and relapse of infection (ROI) was collected from the 
tail vain of rat by making a nip at the tail end. Blood films 
were made by placing a small drop of blood from the tail 
of rat on to a clean glass slide and dropping a clean cover 
slip upon it and a thumb pressed down upon it carefully so 
that the blood film spread evenly. The film was carefully 
examined under the 40伊 objective of a light microscope for 
trypanosomes and the level of parasitaemia were assessed 
using the rapid matching method[9,10]. This was done on 
daily basis after infection for OP and LOP; after treatment for 
COPPT and after clearance for ROI.
2.8. Post-infection survival period (PIST)
  The rats were observed throughout the period of the 
experiment. Rats that were moribund were anaesthetised 
using mild ether anaesthesia and considered dead. The 
mortality date for each rat in each group was recorded after 
which the mean post infection survival time of all the groups 
was calculated.
2.9. Data presentation and statistical analysis
  Data obtained were presented in graph for LOP and as 
means in tables for ROI and COPPT. Data obtained were 
analyzed using ANOVA followed by Duncan post hoc test and 
least significant difference (LSD) to determine the significant 
differences among the means of the various groups. PIST was 
analysed using student t-test. Significance was accepted at 
the level of P<0.05.
3. Results
3.1. Yield of the extract of plant material
  The yield of the extract of the plant material was 7.62% of 
the starting material.
3.2. Acute toxicity
  There was no mortality in all the groups at the end of the 
3-day study period observed for acute toxicity. The faecal 
droppings of all the groups were formed and dry except for 
group E that was pasty. The skin, fur of all the groups looked 
normal.
3.3. Results of selection of the best DDA and MAILE 
combinations for use in the study
  The parasites in all the rats in groups 1, 2, 3, 5 and 6 were 
cleared two days post treatment. Parasites in rats in group 4 
were cleared three days post treatment. The parasites in all 
the rats in groups 7 and 8 were not cleared seven days post 
treatment. However, the parasites in group 9 were cleared 
three days post treatment. The dose used for group 1, 5, and 
9 were chosen for further study.
3.4. Results of efficacy study using combinations of DDA and 
MAILE
3.4.1. Onset of parasitaemia
  Trypanosomes were first noticed in the blood of infected 
rats in groups C and D four days post infection and by the 
sixth day post infection, trypanosomes were detected in all 
the infected rats. Though trypanosomes appeared first in 
groups C and D, the onset of parasitaemia in the infected 
groups were not found to differ significantly (P<0.05).
3.4.2. Level of parasitaemia (LOP)
  The results of the level of parasitaemia (LOP) revealed that 
six days post infection, the mean LOP was not found to differ 
significantly in all the infected groups. However one day 
post treatment, the LOP of groups A, B, and C were found 
to be significantly lower than that of group D which in turn 
was lower (P<0.05) than that of group E and G respectively. 
And that of group E was significantly lower than that of 
group G three days post treatment and this trend continued 
throughout the experimental period (Figure 1).
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Figure 1. The level of parasitaemia in rats infected with T. brucei 
brucei and treated with different combinations of DDA and MAILE. 
Note: Treatment was day 6 post infection.
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3.4.3. Clearance of parasites post treatment (COPPT)
  There was 100% clearance of parasites in groups A, B 
and C whereas 83% of group D parasites were cleared and 
groups E and G had 0% parasite clearance respectively. The 
mean COPPT of rats in group D was significantly longer than 
that of groups C and B. There was no significant difference 
(P<0.05) in the mean COPPT among groups B, C and A; and 
between groups A and D.
3.4.4. Relapse of infection period (RIP) after clearance
  The mean RIP of group D was significantly shorter than 
that of group C, and that of group C was significantly shorter 
(P<0.05) than that of group A. There was no relapse of 
infection in group B.
3.4.5. Post infection survival time (PIST)
  Rats in groups A, B, and C did not die throughout the 
experimental period. Group D had 17% mortality and groups 
E and G had 100% mortality respectively. When the mean 
PIST of group E was compared to group G; it was not found 
to differ (P<0.05) significantly.
 
 
4. Discussion
  The results revealed that of all the doses used for 
acute toxicity, none of the rats in any of the groups died. 
According to WHO acute hazard rankings, the extract can be 
described as unlikely to present hazard in normal use since 
the maximum dose of 3 000 mg/kg body weight (bw) did not 
lead to mortality[13]. In addition, the fact that at the highest 
dose combination (7 mg/kg bw DDA and 3 000 mg/kg bw 
extract); none of the rats died indicated that the combination 
is unlikely to present acute hazard in normal use. The 
parasites in all the rats in groups 1, 2, 3, 5 and 6 were 
cleared two days post treatment. This indicated therapeutic 
superiority of dose combinations used in those groups 
probably due to synergy and potentiation. Parasites in rats 
in group 4 were cleared three days post treatment. The 
parasites in all the rats in groups 7 and 8 were not cleared 
seven days post treatment. However, the parasites in group 9 
were cleared three days post treatment. This result indicated 
that the higher the dose of diminazene and lower dose of 
extract the better the therapeutic effect. Higher dose of the 
extract and lower dose of diminazene is also of therapeutic 
effect provided the diminazene is not less than 1.8 mg/kg bw. 
The dose used for group 1, 5, and 9 were chosen for further 
study. The results of efficacy study using combinations of 
DDA and MAILE, showed no significant different in the mean 
OP in all the infected groups six days post infection, similar 
in effect to the dose response experiments. However, the 
mean LOP differed shortly after treatment among the groups. 
Group B (treated with 7 mg/kg bw DDA plus 125 mg/kg bw 
MAILE) cleared the parasites fastest and group C (treated 
with 3.5 mg/kg bw DDA plus 250 mg/kg bw MAILE) cleared 
the parasites faster than group A (treated with 7 mg/kg bw 
DDA alone) in absolute values may be attributed to the fact 
that the extract have synergistic effect with diminazene. The 
mean COPPT of group D was significantly longer than that 
of groups A, C and B. There was no significant difference in 
the mean COPPT among groups B, C and A. This therapeutic 
superiority which group B has over C, and C over A, 
regarding absolute values of mean COPPT, was equally 
exhibited significantly by groups B, C and A over group D. 
Group E had significantly lower mean LOP when compared 
to group G and this reduction continued throughout the 
experimental period suggesting strongly that the extract on 
its own had trypanocidal effect, a finding consistent with 
the findings of other researcher[8]. In addition, the fact that 
group B had 0% relapse infection, group A, 20% relapse 
infection and group C 40% relapse infection and group D, 
100% relapsed infection showed pharmacological superiority 
of the dose combination used in group B over doses used 
in group C, A and D respectively. Again, group B had no 
relapse of infection whereas the mean RIP of group D was 
significantly shorter than that of group C, and that of group 
C was significantly shorter  than that of group A, showing 
pharmacological superiority of the dose combination used in 
group B over doses used in group C, A and D respectively. 
This pharmacological superiority may be attributed to at 
least three factors: (1) The extract have trypanocidal effect 
on its own, a finding observed by significantly reduced 
level of parasitaemia in group E compared to group G two 
days post treatment, a trend that continued throughout the 
experimental period. (2) The extract may have assisted 
the diminazene to access sites that ordinarily are difficult 
for diminazene to penetrate and destroy all the parasites 
at those sites as observed in lack of relapsed infection in 
group B when compared to group A. (3) It may also be that 
the extract prolonged the half-life of the diminazene, such 
that the drugs stayed longer in the blood than diminazene 
alone and exert longer trypanocidal activity than the single 
therapy observed as zero percent relapsed infection in group 
B and 20% relapsed infection in group A. It should be noted 
that the genetic structure of trypanosome population (clonal 
or panmictic) is an important parameter influenced by the 
transmission intensity, and this in turn might influence 
the rate of development of drug resistance. This has been 
suggested by studies on drug resistance in plasmodium, 
which has shown that parasite populations in infected hosts 
are polyclonal with differing drug sensitivities between the 
clones making up the population. It is likely that a similar 
situation occurs in trypanosome infections[1]. This difference 
in drug sensitivity is probably why the DDA and the extract 
combination were able to clear the trypanosomes which 
DDA alone could not eliminate and without relapse as seen 
in group B. The relapse of infection seen in group A may 
be attributed to the fact that the population sensitive to 
DDA were cleared while those not sensitive to it remained 
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but because of the diagnostic technique used and the 
relative little quantity of the parasites left in the blood, 
there appeared to be total clearance of parasites. However, 
with drug biotransformation and elimination as well as 
with the multiplication of those parasites not sensitive to 
DDA, the parasite multiply and attain a detectable level 
and was observed as relapse of infection seen in group A 
when compared to group B. This population not sensitive 
to DDA could be attributed to be resistant to DDA [3].  The 
observed relapse therefore could be attributed to resistance 
and reappearance of parasites from site not accessible 
to trypanocidal agents (relapse). The aforementioned 
reasons as well as sub therapeutic dosage and probably 
immunosuppression and cross resistance can be attributed 
to the relapse observed in group D,  C and A respectively [1].
  This relapsed infection was observed by other workers[5] at 
days 42 and 49 post treatments with diminazene aceturate 
after the rats were infected with T. brucei alone; and T. 
brucei and T. congolense combination respectively. Group 
C, though had faster clearance rate in absolute values when 
compared to group A, had significantly reduced mean RIP 
probably because of reduction in half-life of dose used in 
group C compared to group A.
  The fact that there was 83% clearance in group D and 
later 100% relapse infection in a much shorter period after 
clearance may be attributed to the fact that the dose was not 
therapeutic enough to clear parasites. The 83% clearance 
was probably due to synergy and potentiation of DDA by the 
MAILE combination, and the 100% relapsed infection may 
be due to reduction in half-life (shorter duration of action) 
occasioned by rapid biotransformation and excretion in that 
group compared to groups A, B and C. This reduction in 
half-life phenomenon needs further investigation. Rats in 
groups A, B and C did not die throughout the experimental 
period probably because of better therapeutic efficacy of the 
doses used. Group D had 17% mortality showing that the 
dose combination used was not as efficacious as the doses 
used in group A, B and C respectively for the treatment 
of T.brucei brucei infection. The 100% relapse infection in 
the ones cleared by the dose combination used in group D 
suggested that this combination is not therapeutic in the 
treatment of trypanosomosis caused by T. brucei brucei.
  The mean PIST of group E when compared to group G did 
not differ significantly which indicated that the extract alone 
did not have any significant effect on survivability. However, 
rats in group E have significantly (P<0.05) lower LOP than 
that of group G throughout the experimental period. This is 
an indication that the extract may have trypanocidal effect, 
but the effect may not be significant enough for possible 
therapeutic application alone. This therapeutic possibility 
may be enhanced if treatment is repeated. Isolation and 
concentration of active ingredient may equally enhance 
therapeutic efficacy. In conclusion, this study has indeed 
established that the combination of 125 mg/kg bw extract 
plus 7 mg/kg bw DDA is very effective in the treatment of 
trypanosomosis caused by T. brucei brucei, as it quickly 
cleared the parasites and prevented relapse infection. It can 
be suggested from the deductions of the study that A. indica 
enhanced diminazene in producing its trypanocidal activity 
in at least three possible different ways namely: potentiation, 
synergy and increase in half-life.
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